NCT04854434 2023-11-03A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS MutationsKaryopharm Therapeutics IncPhase 2 Terminated13 enrolled 14 charts